Almac partners with Exco InTouch

Tuesday, March 22, 2011 11:05 AM

Almac’s Clinical Technologies business unit, a provider of IXRS (Interactive Voice and Web Response) services for patient and drug supply management, has formed an integrated patient management alliance with Exco InTouch, a firm specializing in patient recruitment, retention, compliance and ePRO services. The alliance will focus on the integration of technology and processes by both firms to deliver patient management, compliance, retention and ePRO service offerings to sponsors of clinical trials.

The Almac-Exco InTouch offering serves a need in the drug development process: engaging, retaining and enhancing compliance of patients from the earliest stages of recruitment throughout the course of a trial. Exco InTouch will integrate its retention and compliance technology solutions with Almac’s IXRS technology, an integrated phone and web platform. This will allow patients to receive messages for key elements of their required study conduct using text messages, emails or phone calls. Patients will receive reminders to attend clinic visits or to fill out patient diaries, medication prompts and motivational messages to encourage ongoing participation.

Almac President Jim Murphy said, “The alliance between Almac and Exco InTouch provides sponsors with a practical, cost-effective solution to managing patients during a clinical trial. Our joint solutions will help enhance patient recruitment, retention, and compliance, three highly critical areas of concern for our clients.”

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs